- Home
- CPAC vs PVLA Comparison
CPAC vs PVLA Comparison
Compare CPAC & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAC
- PVLA
- Stock Information
- Founded
- CPAC 1949
- PVLA 2015
- Country
- CPAC Peru
- PVLA United States
- Employees
- CPAC N/A
- PVLA N/A
- Industry
- CPAC Building Materials
- PVLA Biotechnology: Pharmaceutical Preparations
- Sector
- CPAC Industrials
- PVLA Health Care
- Exchange
- CPAC Nasdaq
- PVLA Nasdaq
- Market Cap
- CPAC 580.5M
- PVLA 604.2M
- IPO Year
- CPAC 2012
- PVLA N/A
- Fundamental
- Price
- CPAC $7.43
- PVLA $73.85
- Analyst Decision
- CPAC Hold
- PVLA Strong Buy
- Analyst Count
- CPAC 1
- PVLA 12
- Target Price
- CPAC $6.40
- PVLA $68.67
- AVG Volume (30 Days)
- CPAC 8.6K
- PVLA 199.5K
- Earning Date
- CPAC 10-27-2025
- PVLA 11-15-2025
- Dividend Yield
- CPAC 6.75%
- PVLA N/A
- EPS Growth
- CPAC 26.68
- PVLA N/A
- EPS
- CPAC 0.14
- PVLA N/A
- Revenue
- CPAC $572,828,408.00
- PVLA N/A
- Revenue This Year
- CPAC N/A
- PVLA N/A
- Revenue Next Year
- CPAC N/A
- PVLA N/A
- P/E Ratio
- CPAC $10.14
- PVLA N/A
- Revenue Growth
- CPAC 3.37
- PVLA N/A
- 52 Week Low
- CPAC $5.10
- PVLA $11.17
- 52 Week High
- CPAC $7.50
- PVLA $77.77
- Technical
- Relative Strength Index (RSI)
- CPAC 68.16
- PVLA 59.32
- Support Level
- CPAC $7.13
- PVLA $70.55
- Resistance Level
- CPAC $7.50
- PVLA $77.77
- Average True Range (ATR)
- CPAC 0.16
- PVLA 4.49
- MACD
- CPAC 0.00
- PVLA -0.67
- Stochastic Oscillator
- CPAC 84.44
- PVLA 66.89
About CPAC Cementos Pacasmayo S.A.A. (Each representing five)
Cementos Pacasmayo SAA is a Peruvian cement company that produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production and transportation facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.